Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this observational study is to retrospectively collect current
survival data for patients originally included in axitinib A4061012 [NCT00076011] study to
estimate the 5-year survival rate in subjects with metastatic renal cancer cell treated with
axitinib.